Topical tacrolimus treatment for ocular cicatricial pemphigoid;Traitement d'une localisation oculaire de pemphigoïde cicatricielle par tacrolimus topique

Annales de Dermatologie et de Venereologie

Volumn 133, Issue 2, 2006, Pages 161-164

  Michel, J L ^a   Gain, Ph ^b  

^a Cabinet de Dermatologie   (France)

^b SERVICE DE NEUROLOGIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BASEMENT MEMBRANE ANTIBODY; CHIBROCADRON; CORTISONE; CYCLOPHOSPHAMIDE; DAPSONE; DEXAMETHASONE; EYE DROPS; STERDEX; TACROLIMUS; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBODY DETECTION; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; CONJUNCTIVA; CONJUNCTIVITIS; DISEASE DURATION; DRUG DOSE REGIMEN; DRUG TREATMENT FAILURE; EYE DISEASE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HYPEREOSINOPHILIA; IMMUNOFLUORESCENCE TEST; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; KERATITIS; MOUTH ULCER; MUCOUS MEMBRANE PEMPHIGOID; SCALP; SYMBLEPHARON; TOPICAL TREATMENT; TREATMENT OUTCOME; VISUAL ACUITY; ADHESION; BULLOUS PEMPHIGOID; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE ACTIVATION; T LYMPHOCYTE; TIME; TOPICAL DRUG ADMINISTRATION;

ADHESIONS; ADMINISTRATION, TOPICAL; ADULT; CONJUNCTIVITIS; CYCLOPHOSPHAMIDE; EYE DISEASES; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS, INTRAVENOUS; KERATITIS; LYMPHOCYTE ACTIVATION; PEMPHIGOID, BULLOUS; T-LYMPHOCYTES; TACROLIMUS; TIME FACTORS; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 33646003549     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0151-9638(06)70869-9     Document Type: Article

References (19)

1. Musette P, Pascal F, Hoang-Xuan T, Heller M, Lok C, Deboise A, et al. Treatment of cicatricial pemphigoid with pulse intravenous cyclophosphamide. Arch Dermatol 2001;137:101-2.
2. Alaiti S, Kang S, Fiedler VC, Ellis CN, Spurlin DV, Fader D, et al. Tacrolimus (FK 506) ointment for atopic dermatitis: a phase I study in adults and children. J Am Acad Dermatol 1998;38:69-76.
3. Cheer SM, Plosker GL. Tacrolimus ointment. A review of is therapeutic potential as a topical therapy in atopic dermatitis. Am J Clin Dermatol 2001;2:389-406.
4. Shainhouse T, Eichenfield LF. Long term safety of tacrolimus ointment in children treated for atopic dermatitis. Expert Opin Drug Saf 2003;2:457-65.
5. Sengoku T, Sakuma S, Satoh S, Kishi S, Ogawa T, Ohkubo Y, Mutoh S. Effect of FK506 eye drops on late and delayed-type responses in ocular allergy models. Clin Exp Allergy 2003;33:1555-60.
6. Nishino K, Fukushima A, Okamoto S, Ohashi Y, Fukata K, Ozaki A, Ueno H. Suppression of experimental immune-mediated blepharoconjunctivitis in brown norway rats by topical application of FK506. Graefes Arch Clin Exp Ophthalmol 2002;240:137-43.
7. Edwards A. Immunosuppressant drugs in the treatment of allergic eye disease : do they have potential usage? Clin Exp Allergy 2003;33:1479-80.
8. Sakurai E, Nozaki M, Okabe K, Kunou N, Kimura H, Ogura Y. Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis. Invest Ophthalmol Vis Sci 2003;44:4845-52.
9. Passos E, Genaidy MM, Peyman GA. Ocular toxicity of intravitreal tacrolimus. Ophthalmic Surg Lasers 2002;33:140-4.
10. Reinhard T, Reis A, Mayweg S, Oberhuber H, Mathis G, Sundmacher R. Topical FK506 in inflammatory corneal and conjunctival diseases : a pilot study. Klin Monatsbl Augenheilkd 2002;219:125-31.
11. Ahmad SM, Stegman Z, Fructhman S, Asbell PA. Successful treatment of acute ocular graft-versus-host disease with tacrolimus (FK506). Cornea 2002;21:432-3.
12. Freeman AK, Serle J, VanVeldhuisen P, Lind L, Clarke J, Singer G, Lebwohl M. Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis 2004;73:267-71.
13. Mayer K, Reinhard T, Reis A, Bohringer D, Sundmacher R. FK 506 ointment 0.1%. A new therapeutic option for atopic blepharitis. Clinical trial with 14 patients. Klin Monatsbl Augenheilkd 2001;218:733-6.
14. Letko E, Ahmed AR, Foster CS. Treatment of ocular cicatricial pemphigoid with tacrolimus (FK 506). Graefes Arch Clin Exp Ophthalmol 2001;239:441-4.
15. Sloper CM, Powell RJ, Dua HS. Tacrolimus (FK506) in the management of high-risk corneal and limbal grafts. Ophthalmology 2001;108:1838-44.
16. Gunther C, Wozel G, Meurer M, Pfeiffer C. Topical tacrolimus treatment for cicatricial pemphigoid. J Am Acad Dermatol 2004;50:325-6.
17. Hall VC, Liesegang TJ, Kostick DA, Lookingbill DP. Ocular mucous membrane pemphigoid and ocular pemphigus vulgaris treated topically with tacrolimus ointment. Arch Dermatol 2003;139:1083-4.
18. Lebeau S, Mainetti C, Masouye I, Saurat JH, Borradori L. Localized childhood vulval pemphigoid treated with tacrolimus ointment. Dermatology 2004;208:273-5.
19. Assmann T, Becker J, Ruzicka T, Megahed M. Topical tacrolimus for oral cicatricial pemphigoid. Clin Exp Dermatol 2004;29:674-6.